Skip to main navigation

Sorrento Therapeutics

Search

Client Header Links

  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • Covid-19
    • Immuno-Oncology
    • Pain
    • Lymphatic Delivery System
    • Product Candidates
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC FILINGS
    • Stock
    • Analyst Coverage
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Career
  • Contact

SEC Filing Details

SEC Filing Details

Document Details

Form
3
Filing Date
Aug 21, 2020
Document Date
Aug 18, 2020
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Sorrento Therapeutics
Issuer
SORRENTO THERAPEUTICS, INC.
Filer
ASGHAR NAJJAM

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Tools

  • Print

    Print

  • Email Alerts

    Email Alerts

  • RSS Feeds

    RSS Feeds

  • Email Page

    Email Page

© 2021 Sorrento Therapeutics. All Rights Reserved.

Footer

    Terms of Use Privacy Policy DMCA Trademarks Linking Policy
logo

Client Header Links

  • Who We Are
    • Overview
    • History
    • Leadership
    • Board of Directors
  • Research
    • Pipeline
    • Covid-19
    • Immuno-Oncology
    • Pain
    • Lymphatic Delivery System
    • Product Candidates
  • Manufacturing
  • Subsidiaries
  • Partnership
  • Investors
    • News & Events
      • Events Calendar
      • Presentations
    • SEC FILINGS
    • Stock
    • Analyst Coverage
    • Governance
      • Overview
      • Committee Composition
    • Contact IR
  • Career
  • Contact